These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19941796)

  • 1. Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008.
    Simoens C; Sabbe M; Van Damme P; Beutels P; Arbyn M
    Euro Surveill; 2009 Nov; 14(46):. PubMed ID: 19941796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction of human papillomavirus vaccination in Belgium, Luxembourg and the Netherlands.
    Arbyn M; Simoens C; Van Damme P; Scharpantgen A; Meijer CJ; Beutels P
    Gynecol Obstet Invest; 2010; 70(4):224-32. PubMed ID: 21051840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From non school-based, co-payment to school-based, free Human Papillomavirus vaccination in Flanders (Belgium): a retrospective cohort study describing vaccination coverage, age-specific coverage and socio-economic inequalities.
    Lefevere E; Theeten H; Hens N; De Smet F; Top G; Van Damme P
    Vaccine; 2015 Sep; 33(39):5188-95. PubMed ID: 26254978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus health policy.
    Bryer J
    Policy Polit Nurs Pract; 2010 Feb; 11(1):23-8. PubMed ID: 20628175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coverage of human papillomavirus vaccination during the first year of its introduction in Spain.
    Limia A; Pachón I
    Euro Surveill; 2011 May; 16(21):. PubMed ID: 21632017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficiency of human papillomavirus vaccination--estimates based on Dutch cost effectiveness analyses].
    Westra TA; Daemen T; Postma MJ; Wilschut JC
    Ned Tijdschr Geneeskd; 2009; 153():A356. PubMed ID: 19930733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Like mother, like daughter? Mother's history of cervical cancer screening and daughter's Human Papillomavirus vaccine uptake in Flanders (Belgium).
    Lefevere E; Hens N; Theeten H; Van den Bosch K; Beutels P; De Smet F; Van Damme P
    Vaccine; 2011 Oct; 29(46):8390-6. PubMed ID: 21856360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus vaccine: a paradigm shift for pediatricians.
    Jenson HB
    Curr Opin Pediatr; 2009 Feb; 21(1):112-21. PubMed ID: 19242247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coverage from Ontario, Canada's school-based HPV vaccine program: the first three years.
    Wilson SE; Harris T; Sethi P; Fediurek J; Macdonald L; Deeks SL
    Vaccine; 2013 Jan; 31(5):757-62. PubMed ID: 23246265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insufficient basis for the inclusion of Human papillomavirus vaccination in the National Immunisation Programme in The Netherlands].
    de Kok IM; Habbema JD; Mourits MJ; Coebergh JW; van Leeuwen FE
    Ned Tijdschr Geneeskd; 2008 Sep; 152(37):2001-4. PubMed ID: 18825885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction of human papillomavirus (HPV) vaccination in Sweden.
    Tegnell A; Dillner J; Andrae B
    Euro Surveill; 2009 Feb; 14(6):. PubMed ID: 19215721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.
    Watson M; Shaw D; Molchanoff L; McInnes C
    Aust N Z J Public Health; 2009 Aug; 33(4):365-70. PubMed ID: 19689598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
    Goldie SJ; O'Shea M; Campos NG; Diaz M; Sweet S; Kim SY
    Vaccine; 2008 Jul; 26(32):4080-93. PubMed ID: 18550229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical benefit and cost-effectiveness of human papillomavirus vaccination for adult women in the Netherlands.
    Bogaards JA; Coupé VM; Meijer CJ; Berkhof J
    Vaccine; 2011 Nov; 29(48):8929-36. PubMed ID: 21945961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.
    Julius JM; Ramondeta L; Tipton KA; Lal LS; Schneider K; Smith JA
    Pharmacotherapy; 2011 Mar; 31(3):280-97. PubMed ID: 21361739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge of cervix cancer, human papilloma virus (HPV) and HPV vaccination at the moment of introduction of the vaccine in women in Belgium.
    Donders GG; Gabrovska M; Bellen G; Van Keirsbilck J; Van Den Bosch T; Riphagen I; Verjans M
    Arch Gynecol Obstet; 2008 Apr; 277(4):291-8. PubMed ID: 17965870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
    Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
    Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mothers' preferences and willingness to pay for HPV vaccines in Vinh Long Province, Vietnam.
    Poulos C; Yang JC; Levin C; Van Minh H; Giang KB; Nguyen D
    Soc Sci Med; 2011 Jul; 73(2):226-34. PubMed ID: 21733609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A brief history of economic evaluation for human papillomavirus vaccination policy.
    Beutels P; Jit M
    Sex Health; 2010 Sep; 7(3):352-8. PubMed ID: 20719227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.